A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-037)
Clinical trial NCT07216482 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07216482
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-11
- Primary completion
- 2026-08-12
- Enrollment
- 975
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.